Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer
Shiao et al. reveals the phenotypic and spatial changes that occur in the tumor immune microenvironment following anti-PD-1 therapy and radiation in triple-negative breast cancer. They identify three spatial distributions that associate with early responders, late responders and non-responders.